Takeda Pharmaceutical
TAK
#435
Rank
A$79.18 B
Marketcap
A$25.07
Share price
0.42%
Change (1 day)
10.78%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): A$4.93 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are A$29.86 Billion. , an increase over its 2024 earnings that were of A$3.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 A$4.65 B49.03%
2024 A$3.12 B-2.41%
2023 A$3.20 B-28.14%
2022 A$4.45 B-40.9%
2021 A$7.54 B78.24%
2020 A$4.23 B246.1%
2019 A$1.22 B-48.79%
2018 A$2.38 B-23.64%
2017 A$3.12 B21.7%
2016 A$2.56 B-253.01%
2015 -A$1.68 Billion-159.65%
2014 A$2.81 B13%
2013 A$2.49 B2.46%
2012 A$2.43 B-57.05%
2011 A$5.65 B-10.49%
2010 A$6.32 B-3.99%
2009 A$6.58 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.99 B 908.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.90 B 391.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$14.27 B 206.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.57 B 169.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.78 B 131.51%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$31.40 B 574.24%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$13.86 B 197.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-A$1.11 Billion-123.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
A$1.22 B-73.74%๐Ÿ‡ฎ๐Ÿ‡ณ India